Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2

Simone Bastrup Israelsen, Anton Pottegård, Håkon Sandholdt, Sten Madsbad, Reimar Wernich Thomsen, Thomas Benfield

50 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science